- Home
- MSLE vs CURI Comparison
MSLE vs CURI Comparison
Compare MSLE & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSLE | CURI |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Movies/Entertainment |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.6M | 154.7M |
| IPO Year | 2007 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MSLE | CURI |
|---|---|---|
| Price | $9.92 | $2.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $5.83 |
| AVG Volume (30 Days) | 25.7K | ★ 1.5M |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.36% |
| EPS Growth | N/A | ★ 54.17 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $78,043,000.00 |
| Revenue This Year | N/A | $14.91 |
| Revenue Next Year | N/A | $12.91 |
| P/E Ratio | ★ N/A | $24.50 |
| Revenue Growth | N/A | ★ 9.52 |
| 52 Week Low | $5.44 | $2.30 |
| 52 Week High | $13.39 | $5.51 |
Technical Indicators
Market Signals| Indicator | MSLE | CURI |
|---|---|---|
| Relative Strength Index (RSI) | 55.35 | 50.00 |
| Support Level | $9.10 | $2.32 |
| Resistance Level | $10.22 | $2.95 |
| Average True Range (ATR) | 0.46 | 0.24 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 23.66 | 17.22 |
Price Performance
Historical ComparisonAbout MSLE Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.